Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response.
about
Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysateDendritic cells for specific cancer immunotherapy.Dendritic cells and their potential therapeutic role in haematological malignancy.Dendritic cells from patients with chronic myeloid leukemia: functional and phenotypic features.CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivation.Dendritic cell-based immunotherapy for myeloid leukemias.DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties.Recognition of chronic myelogenous leukaemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells.In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.FISH for BCR-ABL on interphases of peripheral blood neutrophils but not of unselected white cells correlates with bone marrow cytogenetics in CML patients treated with imatinib.Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells.Dendritic cells become BCR-ABL negative in chronic myeloid leukaemia patients successfully treated with imatinib.Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein.
P2860
Q28362580-BED13273-2BEF-476E-BF5A-5991A8100166Q34280913-E961F124-ACB2-4E03-AD89-D5E2718E2748Q35614625-A81EB71C-245B-4FEB-AF5B-0C9138B9F332Q36194635-756397AC-9443-4D2E-870C-E224E94AB43BQ36671187-A7DCA79F-2B7D-4330-987C-5C1D66004028Q37420778-EA180B60-4070-456E-AD49-EA2B57910C2FQ40007199-0E9E16AD-F7B8-485F-9857-FAACF48AEF77Q40819560-4F93086A-2C02-4B24-869C-751782AB3457Q44272941-6E762344-50F4-49ED-9907-B976F928A67BQ44598656-DBEB5EA3-275A-4168-8B87-C3B11D46A80AQ44632359-0FDCB5DB-6DBF-457C-9CE9-D4AC791D9801Q44795662-90F2AC22-20EB-4B05-84FB-CF0C4C5D7BBFQ54369576-AFE6227F-3071-4273-9399-8D8B5FB138AC
P2860
Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Dendritic cells generated from ...... ary cytotoxic T-cell response.
@en
type
label
Dendritic cells generated from ...... ary cytotoxic T-cell response.
@en
prefLabel
Dendritic cells generated from ...... ary cytotoxic T-cell response.
@en
P2093
P2860
P1476
Dendritic cells generated from ...... ary cytotoxic T-cell response.
@en
P2093
Niederwieser D
P2860
P304
P356
10.1002/(SICI)1098-2264(199711)20:3<215::AID-GCC1>3.0.CO;2-5
P577
1997-11-01T00:00:00Z